Status:
ACTIVE_NOT_RECRUITING
Nurse AMIE (Addressing Malignancies in Individuals Everyday)
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Cancer Institute (NCI)
West Virginia University
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.
Detailed Description
After being informed about the details of the study, including risks and potential benefits, participants who give their informed consent will do baseline measurements. After these measures are collec...
Eligibility Criteria
Inclusion
- Patient receiving care for their cancer
- Age: 18+ years of age
- Has stage 3 or 4 cancer, or an unstaged cancer that is considered 'advanced' (greater than stage 2) by their treating oncologist
- Must be within six months of initiation of pharmacologic or radiation treatment, for curative or palliative purposes, from a medical or radiation oncologist
- Clinician-rated ECOG function of 0-3
- Lives in a county with RUCC code 4 - 9 and/or zip code with RUCA code 4-10
- Has access to personal device capable of receiving telephone calls for study facilitator check-ins
- Fluent in written and spoken English
- Sufficient vision/hearing to interact with the tablet and study staff
- Clinician-defined life expectancy of 6 months or more
Exclusion
- Patients with medical or psychiatric conditions documented in the medical record (beyond cancer, its treatments, and its symptoms) that would impair our ability to test study hypotheses (e.g. psychotic disorders, dementia, inability to give informed consent, or follow study instructions).
- Patients who are participating in any other supportive care or behavioral intervention studies.
- Non-English speaking patients will be excluded, as they represent less than 2% of the population targeted.
Key Trial Info
Start Date :
May 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
344 Patients enrolled
Trial Details
Trial ID
NCT05221606
Start Date
May 3 2022
End Date
March 1 2027
Last Update
April 11 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC-Butler
Butler, Pennsylvania, United States, 16001
2
UPMC - Greenville
Greenville, Pennsylvania, United States, 16125
3
Penn State Hershey Medical Center
Hershey, Pennsylvania, United States, 17033
4
UPMC - Indiana
Indiana, Pennsylvania, United States, 15701